|
06 Sep 2025 |
Apollo Hospitals
|
Consensus Share Price Target
|
7804.50 |
8570.10 |
- |
9.81 |
buy
|
|
|
|
|
31 May 2023
|
Apollo Hospitals
|
SMC online
|
7804.50
|
|
4621.95
(68.86%)
|
|
Results Update
|
|
|
|
|
31 May 2023
|
Apollo Hospitals
|
ICICI Direct
|
7804.50
|
5440.00
|
4621.95
(68.86%)
|
Target met |
Buy
|
|
|
|
|
24 Apr 2023
|
Apollo Hospitals
|
Motilal Oswal
|
7804.50
|
5580.00
|
4399.05
(77.41%)
|
Target met |
Buy
|
|
|
|
|
17 Feb 2023
|
Apollo Hospitals
|
ICICI Securities Limited
|
7804.50
|
5052.00
|
4614.70
(69.12%)
|
Target met |
Accumulate
|
|
|
Apollo Hospitals Enterprise’s (AHEL) Q3FY23 performance was a miss vs our estimates. Revenue grew 17.2% YoY to Rs42.6bn led by strong growth in pharmacy business (I-Sec: Rs43.5bn). EBITDA margin was down 140bps QoQ at 11.9%, with higher spend on Apollo 24x7.
|
|
16 Feb 2023
|
Apollo Hospitals
|
Prabhudas Lilladhar
|
7804.50
|
5400.00
|
4643.15
(68.09%)
|
Target met |
Buy
|
|
|
|
|
16 Feb 2023
|
Apollo Hospitals
|
ICICI Direct
|
7804.50
|
5460.00
|
4643.15
(68.09%)
|
Target met |
Buy
|
|
|
|
|
15 Feb 2023
|
Apollo Hospitals
|
SMC online
|
7804.50
|
|
4487.90
(73.90%)
|
|
Results Update
|
|
|
|
|
15 Feb 2023
|
Apollo Hospitals
|
Motilal Oswal
|
7804.50
|
5700.00
|
4487.90
(73.90%)
|
Target met |
Buy
|
|
|
|
|
16 Jan 2023
|
Apollo Hospitals
|
Motilal Oswal
|
7804.50
|
5600.00
|
4294.65
(81.73%)
|
Target met |
Buy
|
|
|
|
|
14 Dec 2022
|
Apollo Hospitals
|
Geojit BNP Paribas
|
7804.50
|
5115.00
|
4596.65
(69.79%)
|
Target met |
Hold
|
|
|
|